Hryhoriy Zhoba

Hryhoriy (Greg) Zhoba is an experienced scientist currently serving as Associate Scientist II at Atalanta Therapeutics since June 2023, leading in vivo and ex vivo analyses for various internal programs. Prior to this role, Zhoba was a Research Associate in Comparative Medicine at Vertex Pharmaceuticals, where involvement in multiple disease areas included type-1 diabetes and myotonic dystrophy type I from June 2022 to June 2023. Previously, Zhoba contributed as a Research Assistant at the VA Boston Healthcare System, focusing on translational research related to TBI and PTSD between November 2021 and June 2022. Zhoba holds a Bachelor of Science degree in Cell and Molecular Neuroscience from Florida State University, completed in July 2021.